We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 2,027 results
  1. Intratumoral gene expression of dihydrofolate reductase and folylpoly-c-glutamate synthetase affects the sensitivity to 5-fluorouracil in non-small cell lung cancer

    Background

    Various factors related to the sensitivity of non-small cell lung carcinoma (NSCLC) to 5-fluorouracil (5-FU) have been reported, and some...

    Kayo Sakon, Masato Sasaki, ... Takaaki Koshiji in Discover Oncology
    Article Open access 25 June 2021
  2. Oral Capecitabine Exposures and Use of Uridine Triacetate: A 20-Year Retrospective Analysis

    Background and Objectives

    Capecitabine is an oral prodrug of 5-fluorouracil. Toxicity can occur during therapy as well as acutely with overdose and...

    Justin A. Seltzer, Nathan A. Friedman, ... Alicia Minns in Clinical Drug Investigation
    Article Open access 19 April 2023
  3. Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands

    Cancer stem-like cells (CSCs) are believed to be responsible for cancer recurrence and metastasis. Therefore, a therapeutic approach is needed to...

    Geng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi in Medical Oncology
    Article 02 March 2023
  4. Cotrimoxazole

    Article 20 August 2022
  5. Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance

    Aberrant function of epigenetic modifiers plays an important role not only in the progression of cancer but also the development of drug resistance....

    Christina Demetriadou, Anastasia Raoukka, ... Antonis Kirmizis in Oncogene
    Article Open access 16 November 2021
  6. Folate and retinal vascular diseases

    Folate, a pteroylglutamic acid derivative, participates in fundamental cellular metabolism. Homocysteine, an amino acid, serves as an intermediate of...

    **yue Gu, Chunyan Lei, Meixia Zhang in BMC Ophthalmology
    Article Open access 13 October 2023
  7. Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study

    Introduction

    Methotrexate (MTX), a folate antagonist, is often used as second-line treatment in patients with sarcoidosis. Effectiveness of MTX has...

    Montse Janssen Bonás, Janani Sundaresan, ... Marcel Veltkamp in Lung
    Article 16 November 2023
  8. Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin

    Purpose

    The aim was to explore the correlation between increasing doses of [6R]-5,10-methylenetetrahydrofolate (arfolitixorin) and plasma...

    Helena Taflin, Elisabeth Odin, ... Yvonne Wettergren in Cancer Chemotherapy and Pharmacology
    Article Open access 24 October 2020
  9. Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia

    Introduction

    Hand-foot syndrome (HFS) significantly impacts quality of life in cancer patients undergoing capecitabine treatment. This study assessed...

    Teck Long King, Pei Jye Voon, ... Dzul Azri Mohamed Noor in Supportive Care in Cancer
    Article Open access 14 May 2024
  10. Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway

    Osteosarcoma is a malignant bone tumor that is prone to metastasize early and primarily affects children and adolescents. Cell migration-inducing...

    Il** Sim, WonGyom Choe, ... WeiQi Yan in Medical Oncology
    Article Open access 05 September 2023
  11. CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis

    Cisplatin, 5FU and docetaxel (TPF) are the most common chemotherapy regimen used for advanced OSCC. However, many cancer patients experience relapse,...

    Sibasish Mohanty, Pallavi Mohapatra, ... Rupesh Dash in Oncogene
    Article Open access 01 October 2022
  12. Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma

    Purpose

    Raltitrexed shows therapeutic effects and safety in many types of malignant tumors. However, reports of the clinical outcomes of...

    Yonghua Bi, Yang Wang, ... **nwei Han in Cancer Imaging
    Article Open access 22 February 2023
  13. Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy

    Purpose

    The transmembrane serine protease 4 (TMPRSS4) gene is upregulated in various human cancers. However, its biological functions in pancreatic...

    Sho Tazuma, Takeshi Sudo, ... Hirotaka Tashiro in Surgery Today
    Article 19 April 2024
  14. Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network

    Mechanisms-of-resistance to decitabine and 5-azacytidine, mainstay treatments for myeloid malignancies, require investigation and countermeasures....

    **aorong Gu, Rita Tohme, ... Yogen Saunthararajah in Leukemia
    Article Open access 07 August 2020
  15. The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients

    Background

    There are currently no validated criteria that entirely explain or predict response to methotrexate (MTX) treatment in rheumatoid arthritis...

    Azhar M. Nomair, Abeer Abdelati, ... Hanan M. Nomeir in Clinical Rheumatology
    Article Open access 05 February 2024
  16. Multiple drugs

    Article 07 May 2022
  17. Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas

    Background

    Melatonin has been shown with anticancer property and therapeutic potential for tumors. However, there lacks a systematic study on the...

    Lu Ao, Li Li, ... Ruixiang Zhou in BMC Gastroenterology
    Article Open access 20 July 2020
  18. Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy

    Since the discovery of Stimulator of Interferon Genes (STING) as an important pivot for cytosolic DNA sensation and interferon (IFN) induction,...

    Zili Zhang, Haifeng Zhou, ... Desheng Hu in Signal Transduction and Targeted Therapy
    Article Open access 23 December 2022
  19. Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma

    Pancreatic adenocarcinoma (PDAC) and lung cancer are expected to represent the most common cancer types worldwide until 2030. Under typical...

    Eman M. Ragab, Doaa M. El Gamal, ... Abeer A. Khamis in European Journal of Medical Research
    Article Open access 08 September 2022
  20. Combined Effects of Annexin A5 Overexpression, 5-Fluorouracil Treatment, and Irradiation on Cell Viability of Caski Cervical Cancer Cell Line

    Cervical cancer is the fourth leading cause of cancer deaths in women globally. Combining gene therapy with chemo- and radiotherapy may improve...

    Faezeh Ramezani, Mohammad Ali Takhshid, ... Pouya Ramezani in Reproductive Sciences
    Article 29 May 2024
Did you find what you were looking for? Share feedback.